What is a hemangioblastoma?
May 16, 2022
Source: Cainiu Health
Dr. Peng Xiaodong
Introduction
Medulloblastoma is a malignant tumor, not benign. It is a highly vascularized tumor composed of primitive neuroectodermal cells and abundant capillaries. It exhibits two histological patterns: solid and desmoplastic/nodular (not “vesicular”). According to the World Health Organization (WHO) classification, medulloblastoma is a primary central nervous system tumor of uncertain origin and is divided into two major molecular subgroups: sporadic (non-hereditary) and hereditary (familial). It most commonly arises in the cerebellum but may also occur in the brainstem or spinal cord. When located in the cerebellum, it often causes gait ataxia (unsteady walking).
Hemangiomas are benign tumors or vascular malformations arising from abnormal proliferation of vascular cells, typically manifesting in the skin and soft tissues. They commonly appear at birth or shortly thereafter. Then, what is a hemangioblastoma?
What Is a Hemangioblastoma?
Hemangioblastomas are benign, highly vascularized tumors composed of stromal cells and abundant capillaries. They present in two primary forms: solid and cystic. According to the World Health Organization (WHO) classification, their cellular origin remains uncertain; they are classified as primary central nervous system (CNS) tumors and subdivided into sporadic (non-hereditary) and familial (hereditary) types. Hemangioblastomas most frequently occur in the cerebellum, brainstem, and spinal cord. Cerebellar lesions may cause gait instability; brainstem involvement can impair respiration and cardiac function; and spinal cord lesions may lead to paraplegia—symptoms varying depending on tumor location.
With timely surgical resection and early diagnosis, patients often achieve long-term survival. Initial symptoms may be absent or subtle—such as mild headache—and neurological deficits may develop gradually. Tumor growth can damage the central nervous system, and compression of the brainstem may result in brainstem ischemia—a potentially life-threatening condition. The most common clinical manifestations include headache, nausea, vomiting, vertigo, sensory disturbances, and motor dysfunction. Surgical resection remains the optimal treatment. Patients are advised to consult neurosurgeons or specialized oncologic neurosurgeons. When surgery is contraindicated or incomplete, adjuvant radiotherapy may be considered postoperatively.
Hemangioblastoma is a true vascular tumor, also known as angioreticuloma or capillary hemangioblastoma, resulting from aberrant development of mesoderm-derived vascular endothelial cells during embryogenesis. We hope this article has been helpful. Wishing you a joyful life and good health!
